Clinical Trial: CML Pediatric ITK Response According to Molecular Identification at Diagnosis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Chronic Myeloid Leukemia
Study Type: OBSERVATIONAL
Official Title: CML Pediatric ITK Response According to Molecular Identification at Diagnosis (CML Piramid
Brief Summary:
Treatment of chronic myeloid leukemia (CML) has been revolutionized by tyrosine kinase inhibitor (TKI).Nevertheless, case of failure and suboptimal response are still observed even in children.Pediatric CML is a rare disease and differs from adult in terms of disease presentation and treatment response underlying a likely different CML biology.Molecular mechanisms that induce resistance to TKI are still poorly characterized except mutations in the tyrosine kinase domain of BCR::ABL1.We propose to search for a…
Read more